Literature DB >> 29169573

Choosing a medication brand: Excipients, food intolerance and prescribing in older people.

Amy Page1, Christopher Etherton-Beer2.   

Abstract

Multiple brands of the same active ingredient may be available for the same strength, administration route and dose form. Generic brands needs to demonstrate bioequivalence to the originator brand, but the appearance of the generic and originator brands are not required to match. This variation is possible because different brands may vary in the excipients used in the formulation. Excipients are inactive ingredients, and typically make up about 90% of the formulation of an individual medication. Individual preferences or requirements may affect tolerance of particular excipients, such as the use of animal products. The different appearance of brands can affect medication management for some people. This review discusses the potential for excipients to alter the individual response to or tolerance of a medication brand.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brands; Excipients; Generic medications

Mesh:

Substances:

Year:  2017        PMID: 29169573     DOI: 10.1016/j.maturitas.2017.11.001

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  3 in total

1.  Knowledge, Perceptions and Attitudes among Sharia Practitioners in Palestine Regarding Halal Pharmaceuticals: An Exploratory Study.

Authors:  Ahmad M Eid; Abdel Naser Zaid; Jamal Zaid Kielani
Journal:  J Relig Health       Date:  2022-06-25

2.  Using animal-derived constituents in anaesthesia and surgery: the case for disclosing to patients.

Authors:  Daniel Rodger; Bruce P Blackshaw
Journal:  BMC Med Ethics       Date:  2019-02-18       Impact factor: 2.652

3.  Retrospective Database Analysis to Explore Patterns and Economic Burden of Switchback to Brand After Generic or Authorized Generic Utilization.

Authors:  Justine Alderfer; Jyoti Aggarwal; Kim Gilchrist; Jose Maria Jimenez Alvir; Joseph Cook; Sang Hee Park; Jennifer M Stephens
Journal:  Clinicoecon Outcomes Res       Date:  2022-04-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.